Friday, November 22, 2019 6:36:44 AM
Recent LPCN News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 02:45:09 PM
- Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session • PR Newswire (US) • 11/18/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 02:35:09 PM
- Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024 • PR Newswire (US) • 11/07/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 11:09:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 09:37:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 01:35:23 PM
- Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea • PR Newswire (US) • 10/31/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:05:33 PM
- Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results • PR Newswire (US) • 10/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 10:04:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 01:30:11 PM
- Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries • PR Newswire (US) • 10/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 01:35:10 PM
- Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 • PR Newswire (US) • 10/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 01:35:22 PM
- Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference • PR Newswire (US) • 09/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:35:10 PM
- Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek® • PR Newswire (US) • 09/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 03:23:16 PM
- Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/27/2024 12:00:00 PM
- Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024 • PR Newswire (US) • 08/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:20:27 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 10:19:03 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:05:52 PM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM